OBJECTIVE: The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in three patients using gadoxetic acid, a newly developed liver-specific MR contrast agent. CONCLUSION: In all three patients, more than 100 liver adenomas revealed no metabolism of the new liver-specific contrast agent in the delayed phase. Because of absent or strongly reduced intracellular uptake of gadoxetic acid in all adenomas during delayed contrast-enhanced series, differentiation of adenomas from dysplastic or malignant lesions was not possible.
OBJECTIVE: The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in three patients using gadoxetic acid, a newly developed liver-specific MR contrast agent. CONCLUSION: In all three patients, more than 100 liver adenomas revealed no metabolism of the new liver-specific contrast agent in the delayed phase. Because of absent or strongly reduced intracellular uptake of gadoxetic acid in all adenomas during delayed contrast-enhanced series, differentiation of adenomas from dysplastic or malignant lesions was not possible.
Authors: Alex Frydrychowicz; Meghan G Lubner; Jeffrey J Brown; Elmar M Merkle; Scott K Nagle; Neil M Rofsky; Scott B Reeder Journal: J Magn Reson Imaging Date: 2012-03 Impact factor: 4.813
Authors: Kiyarash Mohajer; Alex Frydrychowicz; Jessica B Robbins; Agnes G Loeffler; Thomas D Reed; Scott B Reeder Journal: J Magn Reson Imaging Date: 2012-06-04 Impact factor: 4.813
Authors: Michael Haimerl; Max Wächtler; Florian Zeman; Niklas Verloh; Ivan Platzek; Andreas Georg Schreyer; Christian Stroszczynski; Philipp Wiggermann Journal: PLoS One Date: 2014-06-20 Impact factor: 3.240